These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Integration of signals along orthogonal axes of the vertebrate neural tube controls progenitor competence and increases cell diversity. Sasai N; Kutejova E; Briscoe J PLoS Biol; 2014 Jul; 12(7):e1001907. PubMed ID: 25026549 [TBL] [Abstract][Full Text] [Related]
63. SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer. Mazur PK; Reynoird N; Khatri P; Jansen PW; Wilkinson AW; Liu S; Barbash O; Van Aller GS; Huddleston M; Dhanak D; Tummino PJ; Kruger RG; Garcia BA; Butte AJ; Vermeulen M; Sage J; Gozani O Nature; 2014 Jun; 510(7504):283-7. PubMed ID: 24847881 [TBL] [Abstract][Full Text] [Related]
64. Hepatic ERK activity plays a role in energy metabolism. Jiao P; Feng B; Li Y; He Q; Xu H Mol Cell Endocrinol; 2013 Aug; 375(1-2):157-66. PubMed ID: 23732116 [TBL] [Abstract][Full Text] [Related]
66. The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control. Guégan JP; Frémin C; Baffet G Int J Hepatol; 2012; 2012():328372. PubMed ID: 23133759 [TBL] [Abstract][Full Text] [Related]
67. Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial. Falchook GS; Lewis KD; Infante JR; Gordon MS; Vogelzang NJ; DeMarini DJ; Sun P; Moy C; Szabo SA; Roadcap LT; Peddareddigari VG; Lebowitz PF; Le NT; Burris HA; Messersmith WA; O'Dwyer PJ; Kim KB; Flaherty K; Bendell JC; Gonzalez R; Kurzrock R; Fecher LA Lancet Oncol; 2012 Aug; 13(8):782-9. PubMed ID: 22805292 [TBL] [Abstract][Full Text] [Related]
68. MAPK/ERK-dependent translation factor hyperactivation and dysregulated laminin γ2 expression in oral dysplasia and squamous cell carcinoma. Degen M; Natarajan E; Barron P; Widlund HR; Rheinwald JG Am J Pathol; 2012 Jun; 180(6):2462-78. PubMed ID: 22546478 [TBL] [Abstract][Full Text] [Related]
69. The PKCθ pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells. Belguise K; Milord S; Galtier F; Moquet-Torcy G; Piechaczyk M; Chalbos D Oncogene; 2012 Nov; 31(47):4889-97. PubMed ID: 22286759 [TBL] [Abstract][Full Text] [Related]
70. Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIFα. Chen AY; Kleiboeker S; Qiu J PLoS Pathog; 2011 Jun; 7(6):e1002088. PubMed ID: 21698228 [TBL] [Abstract][Full Text] [Related]
71. The extracellular regulated kinase-1 (ERK1) controls regulated alpha-secretase-mediated processing, promoter transactivation, and mRNA levels of the cellular prion protein. Cissé M; Duplan E; Guillot-Sestier MV; Rumigny J; Bauer C; Pagès G; Orzechowski HD; Slack BE; Checler F; Vincent B J Biol Chem; 2011 Aug; 286(33):29192-29206. PubMed ID: 21586567 [TBL] [Abstract][Full Text] [Related]
73. From basic research to clinical development of MEK1/2 inhibitors for cancer therapy. Frémin C; Meloche S J Hematol Oncol; 2010 Feb; 3():8. PubMed ID: 20149254 [TBL] [Abstract][Full Text] [Related]
74. Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas. Frank MJ; Dawson DW; Bensinger SJ; Hong JS; Knosp WM; Xu L; Balatoni CE; Allen EL; Shen RR; Bar-Sagi D; Martin GR; Teitell MA Blood; 2009 Mar; 113(11):2478-87. PubMed ID: 19147787 [TBL] [Abstract][Full Text] [Related]
75. Kaempferol induces cell death through ERK and Akt-dependent down-regulation of XIAP and survivin in human glioma cells. Jeong JC; Kim MS; Kim TH; Kim YK Neurochem Res; 2009 May; 34(5):991-1001. PubMed ID: 18949556 [TBL] [Abstract][Full Text] [Related]
76. Erk5 controls Slug expression and keratinocyte activation during wound healing. Arnoux V; Nassour M; L'Helgoualc'h A; Hipskind RA; Savagner P Mol Biol Cell; 2008 Nov; 19(11):4738-49. PubMed ID: 18716062 [TBL] [Abstract][Full Text] [Related]
77. Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer. Basbous J; Chalbos D; Hipskind R; Jariel-Encontre I; Piechaczyk M Mol Cell Biol; 2007 Jun; 27(11):3936-50. PubMed ID: 17371847 [TBL] [Abstract][Full Text] [Related]
78. The gatekeeper residue controls autoactivation of ERK2 via a pathway of intramolecular connectivity. Emrick MA; Lee T; Starkey PJ; Mumby MC; Resing KA; Ahn NG Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18101-6. PubMed ID: 17114285 [TBL] [Abstract][Full Text] [Related]
79. The mammalian mitogen activated protein kinase network. Lenormand P Clin Mol Pathol; 1995 Dec; 48(6):M292-301. PubMed ID: 16696026 [No Abstract] [Full Text] [Related]
80. The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence. Kortum RL; Johnson HJ; Costanzo DL; Volle DJ; Razidlo GL; Fusello AM; Shaw AS; Lewis RE Mol Cell Biol; 2006 Mar; 26(6):2202-14. PubMed ID: 16507997 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]